AskGene Pharma, Inc.
Quick facts
Phase 3 pipeline
- ASKB589 · Diabetes
ASKB589 is a small molecule inhibitor of the SGLT2 receptor.
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: